Abstract
The analysis and separation of chiral compounds with wide polar range by supercritical fluid chromatography is of major importance in the process of drug development and quality control. In this work, a fast and reliable enantioselective method for the simultaneous quantitative determination of 8 DBZ-related enantiomers has been successfully developed by supercritical fluid chromatography using an amylose-based reversed-chiral stationary phase. Within less than seven minutes all target compounds could be baseline resolved, using a mobile phase comprising supercritical carbon dioxide and methanol with 0.05 % H3PO4. The optimum chiral stationary phase showed to be a CHIRALPAK® AD-RH column, operated at flow rate of 3.0 mL/min, back pressure of 150 bar and temperature of 40 °C. Method validation confirmed that the developed procedure was selective, linear (r2 > 0.998), accurate (recovery rates: 98.02–100.02 %), and precise (intra-day: 0.05–1.98 %, inter-day: 0.08–1.98 %); the limit of detection and limit of quantification were 0.13–0.55 μg/mL and 0.37–1.68 μg/mL on column, respectively. After initial evaluation of stability according to the ICH Q1A (R2) guideline, R-DBZ showed good stability. Thus, this developed method can be used for assessing the stability of bulk DBZ samples, dosage forms of DBZ and also for monitoring the synthetic procedures of DBZ.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
